ViVitro Labs will highlight the ViVitro Endovascular Simulator, SuperPump, and Pulse Duplicator with Model Left Heart for cardiovascular device testing and research in booth 741 at TCT 2018 from September 21-September 25, 2018 in San Diego, California.
ViVitro Labs Major Accounts Manager Douglas Bigrigg, Product Manager Joe McMahen, and Office Manager Janet Murray will be on hand to demonstrate products and answer any questions.
The ViVitro Labs Endovascular Simulator provides physiological pulsatile flow and pressures mimicking endovascular procedures in a clinically relevant environment. It is designed for simulated-use testing and endovascular simulation training of endovascular devices. ISO 5840, ISO 25539, and ISO 7198 standards include simulated use guidelines. The Endovascular Simulator provides functional design testing for:
The Pulse Duplicator simulates the function of the heart (left or right) by generating pulsatile flow through prosthetic heart valves placed in the Model Left Heart. Powered by the ViVitro SuperPump, it is composed of the Model Left Heart, SuperPump, Flow Measuring System and ViViTest data acquisition system. The components work together to assess the performance of prosthetic heart valves under simulated cardiac conditions. The Pulse Duplicator System is used by the US Food and Drug Administration and is recognised by regulatory bodies worldwide including TÜV, BSI and the Chinese SFDA.
The SuperPump provides maximum operator control with precision accuracy. The pump can be controlled by preconfigured waveforms or by customizable ViViTest software input.
Transcatheter Cardiovascular Therapeutics (TCT) is the world’s largest and most important educational meeting specializing in interventional cardiovascular medicine. For 30 years, TCT has been the center of cutting-edge educational content, showcasing the latest advances in current therapies and clinical research. We hope that our longstanding commitment to lifesaving innovation translates into improved patient care.
About ViVitro Labs
ViVitro Labs Inc. offers industry-leading cardiovascular test equipment and related laboratory testing and consulting services. Hundreds of organizations in over 40 countries for more than 30 years have trusted ViVitro expertise, accuracy, and quality for their heart valve, LVAD, TAH, stent, and graft testing. ViVitro Laboratory Services holds ISO/IEC 17025 accreditation based on ISO 5840. ViVitro products are manufactured by StarFish Medical. ViVitro’s A2LA Scope of Accreditation includes the physical and mechanical testing of heart valve substitutes.
For more information please contact:
# # #